Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOSONICS LIMITED Call Transcript 2014

Oct 15, 2014

65405_rns_2014-10-15_daef6f41-8985-48f9-b814-6ccc62df0a6f.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [202 x 57] intentionally omitted <==

16 October 2014

Company Announcements Office Australian Securities Exchange

Quarterly conference call: AMENDED dial in details

Please note below updated details for the Nanosonics (ASX.NAN) conference call to be held on Monday, October 20, 2014 at 11.00am ADST.

The call will cover the latest Appendix 4C released by Nanosonics (ASX.NAN) to the ASX today.

The amended conference call details are:

Conference ID: 257 970

Dial in numbers:

Australia 1800 558 698 Canada 1855 8811 339 China 4001 200 659 Hong Kong 800 966 806 India 0008 0010 08443 Japan 0053 116 1281 New Zealand 0800 453 055 Singapore 800 101 2785 United Kingdom 0800 051 8245 United States 1855 8811 339

An archive of the call will be available at : http://www.openbriefing.com/OB/1611.aspx and on the company’s website: www.nanosonics.com.au

Michael Kavanagh CEO / President

For more information please contact:

Michael Kavanagh, CEO / President or McGregor Grant, CFO, on (02) 8063 1600 Kyahn Williamson, Investor Relations, Buchan Consulting on (03) 9866 4722 / [email protected]

Ben Oliver, Media Relations, Buchan Consulting on (03) 9866 4722 / [email protected]

About Nanosonics

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets. Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries. For more information about Nanosonics please visit www.nanosonics.com.au

Nanosonics Limited ABN 11 095 076 896 Unit 24 566 Gardeners Road, Alexandria NSW 2015 Australia Tel: +61 2 8063 1600 Fax: +61 2 8063 1600 Email: [email protected] w: www.nanosonics.com.au